Search Results

There are 7765 results for: content related to: Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B

  1. On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients

    Liver International

    Volume 35, Issue 5, May 2015, Pages: 1540–1548, Ioannis Goulis, Stylianos Karatapanis, Evangelos Akriviadis, Melanie Deutsch, George N. Dalekos, Maria Raptopoulou-Gigi, Konstantinos Mimidis, George Germanidis, Christos Drakoulis, Christos Triantos, Elias Zintzaras, Georgios Bakalos and George Papatheodoridis

    Version of Record online : 20 NOV 2014, DOI: 10.1111/liv.12725

  2. You have free access to this content
    AASLD Abstracts 895–1142

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 707A–816A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22644

  3. You have free access to this content
    Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin

    Alimentary Pharmacology & Therapeutics

    Volume 27, Issue 5, March 2008, Pages: 433–440, V. K. RUSTGI, S. ESPOSITO, F. M. HAMZEH and M. L. SHIFFMAN

    Version of Record online : 10 DEC 2007, DOI: 10.1111/j.1365-2036.2007.03587.x

  4. You have free access to this content
    Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels

    Hepatology

    Volume 52, Issue 2, August 2010, Pages: 454–461, Vincent Rijckborst, Bettina E. Hansen, Yilmaz Cakaloglu, Peter Ferenci, Fehmi Tabak, Meral Akdogan, Krzysztof Simon, Ulus S. Akarca, Robert Flisiak, Elke Verhey, Anneke J. Van Vuuren, Charles A. B. Boucher, Martijn J. ter Borg and Harry L. A. Janssen

    Version of Record online : 19 APR 2010, DOI: 10.1002/hep.23722

  5. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  6. Estimating the likelihood of sustained virological response in chronic hepatitis C therapy

    Journal of Viral Hepatitis

    Volume 18, Issue 4, April 2011, Pages: e81–e90, S. Mauss, D. Hueppe, C. John, J Goelz, R. Heyne, B. Moeller, R. Link, G. Teuber, A. Herrmann, M. Spelter, S. Wollschlaeger, A. Baumgarten, K.-G. Simon, N. Dikopoulos and T. Witthoeft

    Version of Record online : 16 SEP 2010, DOI: 10.1111/j.1365-2893.2010.01372.x

  7. You have free access to this content
    Poster Sessions

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 92A–207A,

    Version of Record online : 1 OCT 2013, DOI: 10.1002/hep.26726

  8. You have free access to this content
    Randomised clinical trial: efficacy of peginterferon alfa-2a in HBeAg positive chronic hepatitis B patients with lamivudine resistance

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 4, August 2011, Pages: 424–431, J. Sun, J.-L. Hou, Q. Xie, X.-H. Li, J.-M. Zhang, Y.-M. Wang, H. Wang, J.-Y. Lai, S.-J. Chen, J.-D. Jia, J.-F. Sheng, H. L. Y. Chan, J.-F. Wang, M. K. K. Li, M. Jiang, M. Popescu and J. J. Y. Sung

    Version of Record online : 22 JUN 2011, DOI: 10.1111/j.1365-2036.2011.04750.x

  9. You have free access to this content
    Early serum HBsAg level as a strong predictor of sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 4, February 2012, Pages: 458–468, C.-Y. Peng, H.-C. Lai, Y.-F. Li, W.-P. Su, P.-H. Chuang and J.-T. Kao

    Version of Record online : 8 JAN 2012, DOI: 10.1111/j.1365-2036.2011.04973.x

  10. Peginterferon Alfa-2a Does Not Alter the Pharmacokinetics of Methadone in Patients with Chronic Hepatitis C Undergoing Methadone Maintenance Therapy

    Clinical Pharmacology & Therapeutics

    Volume 77, Issue 3, March 2005, Pages: 214–224, Mark Sulkowski, Teresa Wright, Stephen Rossi, Sanjeev Arora, Matthew Lamb, Ka Wang, Jean-Michel Gries and Sreeni Yalamanchili

    Version of Record online : 7 MAR 2005, DOI: 10.1016/j.clpt.2004.09.008

  11. You have free access to this content
    Peginterferon alfa-2a for hepatitis C after liver transplantation: Two randomized, controlled trials

    Hepatology

    Volume 41, Issue 2, February 2005, Pages: 289–298, Naga Chalasani, Cosme Manzarbeitia, Peter Ferenci, Wolfgang Vogel, Robert J. Fontana, Michael Voigt, Caroline Riely, Paul Martin, Lewis Teperman, James Jiao and Juan Carlos Lopez-Talavera

    Version of Record online : 19 JAN 2005, DOI: 10.1002/hep.20560

  12. You have free access to this content
    Pharmacodynamics of peginterferon alfa-2a and peginterferon alfa-2b in interferon-naïve patients with chronic hepatitis C: a randomized, controlled study

    Alimentary Pharmacology & Therapeutics

    Volume 26, Issue 3, August 2007, Pages: 369–376, R. BRUNO, P. SACCHI, C. SCAGNOLARI, F. TORRIANI, L. MAIOCCHI, S. PATRUNO, F. BELLOMI, G. FILICE and G. ANTONELLI

    Version of Record online : 29 MAY 2007, DOI: 10.1111/j.1365-2036.2007.03392.x

  13. Cost-effectiveness of peginterferon alfa-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan

    Journal of Gastroenterology and Hepatology

    Volume 22, Issue 9, September 2007, Pages: 1494–1499, Sean D Sullivan, David L Veenstra, Pei-Jer Chen, Ting-Tsung Chang, Wan-Long Chuang, Chiaming Tsai and Kavita Patel

    Version of Record online : 16 JUN 2006, DOI: 10.1111/j.1440-1746.2006.04539.x

  14. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  15. You have free access to this content
    Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: Randomized study of higher doses of peginterferon α-2a and ribavirin

    Hepatology

    Volume 48, Issue 4, October 2008, Pages: 1033–1043, Michael W. Fried, Donald M. Jensen, Maribel Rodriguez-Torres, Lisa M. Nyberg, Adrian M. Di Bisceglie, Timothy R. Morgan, Paul J. Pockros, Amy Lin, Lisa Cupelli, Frank Duff, Ka Wang and David R. Nelson

    Version of Record online : 9 JUN 2008, DOI: 10.1002/hep.22448

  16. You have free access to this content
    Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C

    Hepatology

    Volume 46, Issue 3, September 2007, Pages: 640–648, Nicole Forestier, Hendrik W. Reesink, Christine J. Weegink, Lindsay McNair, Tara L. Kieffer, Hui-May Chu, Susan Purdy, Peter L.M. Jansen and Stefan Zeuzem

    Version of Record online : 24 AUG 2007, DOI: 10.1002/hep.21774

  17. You have free access to this content
    HBeAg-Negative Chronic Hepatitis B: Cost-Effectiveness of Peginterferon Alfa-2a Compared to Lamivudine in Taiwan

    Value in Health

    Volume 11, Issue 2, March/April 2008, Pages: 131–138, David L. Veenstra, Sean D. Sullivan, Ming-Yang Lai, Chuan-Mo Lee, Chia-Ming Tsai and Kavita K. Patel

    Version of Record online : 17 JUL 2007, DOI: 10.1111/j.1524-4733.2007.00221.x

  18. You have free access to this content
    Diagnosis, management, and treatment of hepatitis C: An update

    Hepatology

    Volume 49, Issue 4, April 2009, Pages: 1335–1374, Marc G. Ghany, Doris B. Strader, David L. Thomas and Leonard B. Seeff

    Version of Record online : 2 DEC 2008, DOI: 10.1002/hep.22759

  19. Peginterferon alfa-2a and ribavirin for chronic hepatitis C genotype 1 infections in black patients: safety, tolerability and impact on sustained virologic response

    Journal of Viral Hepatitis

    Volume 13, Issue 6, June 2006, Pages: 371–376, C. D. Howell, L. S. Jeffers, W. Cassidy, K. R. Reddy, S. Hu and J. S. Lee

    Version of Record online : 3 APR 2006, DOI: 10.1111/j.1365-2893.2005.00697.x

  20. You have free access to this content
    Results of the IDEAL trial: “Mirror, mirror on the wall … Which's the fairest peg-interferon of them all?”

    Hepatology

    Volume 50, Issue 6, December 2009, Pages: 2034–2037, Julian Schulze zur Wiesch and Ansgar W. Lohse

    Version of Record online : 20 NOV 2009, DOI: 10.1002/hep.23376